DK1313481T3 - Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser - Google Patents

Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser

Info

Publication number
DK1313481T3
DK1313481T3 DK01954214T DK01954214T DK1313481T3 DK 1313481 T3 DK1313481 T3 DK 1313481T3 DK 01954214 T DK01954214 T DK 01954214T DK 01954214 T DK01954214 T DK 01954214T DK 1313481 T3 DK1313481 T3 DK 1313481T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
indole compounds
condensed indole
condensed
compounds
Prior art date
Application number
DK01954214T
Other languages
Danish (da)
English (en)
Inventor
Philip Christopher Buxton
Schie Dirk Marinus J Van
Seona Thomson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0019524A external-priority patent/GB0019524D0/en
Priority claimed from GB0118919A external-priority patent/GB0118919D0/en
Priority claimed from GB0119022A external-priority patent/GB0119022D0/en
Priority claimed from PCT/GB2001/003544 external-priority patent/WO2002011766A2/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1313481T3 publication Critical patent/DK1313481T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01954214T 2000-08-08 2001-08-08 Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser DK1313481T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0019524A GB0019524D0 (en) 2000-08-08 2000-08-08 Novel use
GB0118919A GB0118919D0 (en) 2001-08-02 2001-08-02 Novel use
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use
PCT/GB2001/003544 WO2002011766A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
PCT/GB2001/003590 WO2002011733A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound

Publications (1)

Publication Number Publication Date
DK1313481T3 true DK1313481T3 (da) 2008-01-28

Family

ID=27447871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954214T DK1313481T3 (da) 2000-08-08 2001-08-08 Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser

Country Status (8)

Country Link
EP (1) EP1313481B1 (enExample)
JP (1) JP2004505920A (enExample)
AU (2) AU2001276558B2 (enExample)
CA (1) CA2418921C (enExample)
DE (1) DE60130667T2 (enExample)
DK (1) DK1313481T3 (enExample)
ES (1) ES2294012T3 (enExample)
WO (1) WO2002011733A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263949T3 (es) * 2002-02-14 2006-12-16 Glaxo Group Limited Composicion farmaceutica que comprende n-((1-n-butil-4-piperidinil)mentil)-3,4-dihidro-2h-(1,3)oxazino (3,2-aindol-10-carboxamida o una sal de la misma y procedimiento para su preparacon que comprende granulacion por via seca.
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
FR3097215B1 (fr) 2019-06-13 2021-06-11 Sodimas Installation d’ascenseur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332830A1 (de) * 1982-09-16 1984-03-22 The Upjohn Co., 49001 Kalamazoo, Mich. Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden
ATE180785T1 (de) * 1992-03-12 1999-06-15 Smithkline Beecham Plc Kondensierte indol-derivate als 5-ht4-rezeptor- antagonisten

Also Published As

Publication number Publication date
EP1313481B1 (en) 2007-09-26
DE60130667T2 (de) 2008-07-17
JP2004505920A (ja) 2004-02-26
CA2418921A1 (en) 2002-02-14
EP1313481A1 (en) 2003-05-28
WO2002011733A1 (en) 2002-02-14
AU2001276558B2 (en) 2005-11-24
CA2418921C (en) 2010-10-26
ES2294012T3 (es) 2008-04-01
AU7655801A (en) 2002-02-18
DE60130667D1 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
ITTO20000779A0 (it) Composizioni farmaceutiche.
ITTO20010005A0 (it) Formulazione farmaceutica.
DK1397364T3 (da) Hidtil ukendte pyrrolderivater som farmaceutiske midler
NO20025450L (no) Ny farmasöytisk sammensetning
DK1524266T3 (da) Farmaceutisk sammensætning
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20011478L (fi) Farmaseuttinen koostumus
ITMI20010748A0 (it) Composizioni farmaceutiche
MXPA03001425A (es) Compuestos farmaceuticos.
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
DK1309317T3 (da) Farmaceutiske præparater, der omfatter amlodipinmaleat
NO20032142L (no) Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister
DK1248784T3 (da) Kondenserede azepiner som vasopressinagonister
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
NO20026123L (no) Farmasöytiske sammensetninger
NO20032614L (no) Farmasöytisk sammensetning som har forbedret absorberbarhet
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20031095D0 (no) Farmasöytiske sammensetninger
AR028248A1 (es) Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
DK1313481T3 (da) Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
MXPA03001857A (es) Composicones medicinales.
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet